JNJ Sale Disclosure
Hon. Thomas H. Kean JR · U.S. House PTR · Filed Feb 19, 2026
Sale
Reported value range
$15K - $50K
Hon. Thomas H. Kean JR
U.S. House member
JNJ
Transaction date
Jan 23, 2026
Public filing date
Feb 19, 2026
Filing lag
Filed 27 days later
JNJ daily price context
Close on/before transaction
$220.14
Jan 23, 2026
First close after public filing
$242.49
Feb 20, 2026
30-day return after filing
-2.92%
Through Mar 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- ST
- Security
- Johnson & Johnson Common Stock (JNJ) [ST]
- Quantity / price
- Not reported
- Transaction code
- S
- Form
- P
- Filing identifier
- house_ptr:2026:20034025:3
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
6
Estimated value
$121.5K
Buys / sales
1 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Abbott Laboratories Common Stock ABT | Buy | Jan 29, 2026 | $1K - $15K |
| Johnson & Johnson Common Stock JNJ Current | Sale | Jan 23, 2026 | $15K - $50K |
| Markel Group Inc. Common Stock MKL | Sale | Jan 23, 2026 | $15K - $50K |
| Microsoft Corporation - Common Stock MSFT | Sale | Jan 23, 2026 | $1K - $15K |
| Stryker Corporation Common Stock SYK | Sale | Jan 23, 2026 | $15K - $50K |
| General Motors Company Common Stock GM | Sale | Jan 7, 2026 | $1K - $15K |